• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

头孢噻肟与选定的β-内酰胺类抗生素对流感嗜血杆菌和需氧革兰氏阴性杆菌的比较活性。

Comparative activity of cefotaxime and selected beta-lactam antibiotics against Haemophilus influenzae and aerobic gram-negative bacilli.

作者信息

Dabernat H J, Delmas C

出版信息

Rev Infect Dis. 1982 Sep-Oct;4 Suppl:S401-5. doi: 10.1093/clinids/4.supplement_2.s401.

DOI:10.1093/clinids/4.supplement_2.s401
PMID:6294790
Abstract

The activity of cefotaxime was compared with that of ampicillin, moxalactam, and cefoperozone against 50 isolates of Haemophilus influenzae and with that of ampicillin, carbenicillin, cephalothin, cefoxitin, cefamandole, cefazolin, and several other established and investigational beta-lactam antibiotics against several hundred isolates of gram-negative aerobic enteric bacilli. Minimal inhibitory concentrations of the drugs were determined by the agar plate dilution technique for H. influenzae and by the microtiter broth dilution technique for the other pathogens. Cefotaxime was the most active agent against H. influenzae; it was 20 times more active than ampicillin. It was also the most active agent against Escherichia coli, Klebsiella pneumoniae, nontyphoid Salmonella species, and Yersinia enterocolitica. Cefotaxime was among the most active agents against Enterobacter cloacae, Citrobacter species, Shigella species, Proteus mirabilis, and Acinetobacter calcoaceticus. None of the new cephalosporins or penicillin inhibited greater than 90% of the isolates of Pseudomonas aeruginosa at concentrations of less than or equal to 16 micrograms/ml; these drugs were, however, more active than carbenicillin.

摘要

将头孢噻肟与氨苄西林、拉氧头孢和头孢哌酮对50株流感嗜血杆菌的活性进行了比较,并将其与氨苄西林、羧苄西林、头孢噻吩、头孢西丁、头孢孟多、头孢唑林以及其他几种已上市和正在研究的β-内酰胺类抗生素对数百株革兰氏阴性需氧肠道杆菌的活性进行了比较。采用琼脂平板稀释法测定药物对流感嗜血杆菌的最低抑菌浓度,采用微量肉汤稀释法测定对其他病原体的最低抑菌浓度。头孢噻肟是对流感嗜血杆菌活性最强的药物;其活性比氨苄西林高20倍。它也是对大肠杆菌、肺炎克雷伯菌、非伤寒沙门氏菌和小肠结肠炎耶尔森菌活性最强的药物。头孢噻肟是对阴沟肠杆菌、柠檬酸杆菌属、志贺菌属、奇异变形杆菌和醋酸钙不动杆菌活性最强的药物之一。在浓度小于或等于16微克/毫升时,没有一种新型头孢菌素或青霉素能抑制超过90%的铜绿假单胞菌分离株;然而,这些药物比羧苄西林活性更强。

相似文献

1
Comparative activity of cefotaxime and selected beta-lactam antibiotics against Haemophilus influenzae and aerobic gram-negative bacilli.头孢噻肟与选定的β-内酰胺类抗生素对流感嗜血杆菌和需氧革兰氏阴性杆菌的比较活性。
Rev Infect Dis. 1982 Sep-Oct;4 Suppl:S401-5. doi: 10.1093/clinids/4.supplement_2.s401.
2
Comparative activities of the oxa-beta-lactam LY127935, cefotaxime, cefoperazone, cefamandole, and ticarcillin against multiply resistant gram-negative bacilli.氧杂β-内酰胺类LY127935、头孢噻肟、头孢哌酮、头孢孟多和替卡西林对多重耐药革兰氏阴性杆菌的比较活性。
Antimicrob Agents Chemother. 1980 Feb;17(2):273-9. doi: 10.1128/AAC.17.2.273.
3
In vitro antimicrobial activity of cefoperazone, cefotaxime, moxalactam (LY127935), azlocillin, mezlocillin, and other beta-lactam antibiotics against Neisseria gonorrhoeae and Haemophilus influenzae, including beta-lactamase-producing strains.头孢哌酮、头孢噻肟、拉氧头孢(LY127935)、阿洛西林、美洛西林及其他β-内酰胺类抗生素对淋病奈瑟菌和流感嗜血杆菌的体外抗菌活性,包括产β-内酰胺酶菌株。
Antimicrob Agents Chemother. 1980 Apr;17(4):757-61. doi: 10.1128/AAC.17.4.757.
4
In vitro activities of moxalactam and cefotaxime against aerobic gram-negative bacilli.羟羧氧酰胺菌素和头孢噻肟对需氧革兰氏阴性杆菌的体外活性
Antimicrob Agents Chemother. 1980 Jun;17(6):937-42. doi: 10.1128/AAC.17.6.937.
5
In vitro activities of cefotaxime and moxalactam (LY127935) against Haemophilus influenzae.头孢噻肟和莫拉卡坦(LY127935)对流感嗜血杆菌的体外活性。
Antimicrob Agents Chemother. 1980 Mar;17(3):516-7. doi: 10.1128/AAC.17.3.516.
6
In vitro studies of moxalactam (LY127935), a new beta-lactam antibiotic with significant activity against gram-negative bacteria.对新型β-内酰胺抗生素莫拉西林(LY127935)进行的体外研究,该抗生素对革兰氏阴性菌具有显著活性。
Infection. 1980;8 Suppl 3:S 261-7. doi: 10.1007/BF01639592.
7
Comparative synergistic activity of cefoperazone, cefotaxime, moxalactam, and carbenicillin, combined with tobramycin, against Pseudomonas aeruginosa.头孢哌酮、头孢噻肟、拉氧头孢和羧苄西林与妥布霉素联合应用对铜绿假单胞菌的比较协同活性。
Antimicrob Agents Chemother. 1981 Feb;19(2):332-4. doi: 10.1128/AAC.19.2.332.
8
[Comparative study of ceftriaxone, cefotaxime and moxalactam against 150 Gram negative strains (author's transl)].头孢曲松、头孢噻肟和拉氧头孢对150株革兰氏阴性菌的比较研究(作者译)
Pathol Biol (Paris). 1982 Jun;30(6):341-4.
9
Comparative activities of cefotaxime, a new cephalosporin derivative, and of selected beta-lactam antibiotics against Haemophilus species.新型头孢菌素衍生物头孢噻肟与选定的β-内酰胺类抗生素对嗜血杆菌属的比较活性
Ann Microbiol (Paris). 1979 May-Jun;130 A(4):461-7.
10
Inoculum size effect on the MIC of cefoperazone, moxalactam, cefotaxime, cefoxitin and cephalothin for 118 strains of Haemophilus influenzae including 'tolerant' micro-organisms.接种量对118株流感嗜血杆菌(包括“耐受”微生物)的头孢哌酮、拉氧头孢、头孢噻肟、头孢西丁和头孢噻吩最低抑菌浓度的影响
J Antimicrob Chemother. 1982 Nov;10(5):397-402. doi: 10.1093/jac/10.5.397.

引用本文的文献

1
Moxalactam (latamoxef). A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.拉氧头孢。对其抗菌活性、药代动力学特性及治疗用途的综述。
Drugs. 1983 Oct;26(4):279-333. doi: 10.2165/00003495-198326040-00001.
2
Ceftriaxone. A review of its antibacterial activity, pharmacological properties and therapeutic use.头孢曲松。对其抗菌活性、药理特性及治疗用途的综述。
Drugs. 1984 Jun;27(6):469-527. doi: 10.2165/00003495-198427060-00001.
3
In vitro activity of second and third generation cephalosporins against ampicillin susceptible and resistant haemophilus influenzae.
Infection. 1988 Sep-Oct;16(5):293-6. doi: 10.1007/BF01645075.